Literature DB >> 12759463

HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children.

Zachary A Scott1, Coreen M Beaumier, Mark Sharkey, Mario Stevenson, Katherine Luzuriaga.   

Abstract

This study investigated the relationship between HIV-1 replication and virus (HIV-1; CMV)-specific CD4(+) T cell frequency and function in HIV-1-infected children. HIV-1 gag p55-specific CD4(+) T cell IFN-gamma responses were detected in the majority of children studied. p55-specific responses were detected less commonly and at lower frequencies in children with <50 copies/ml plasma HIV-1 RNA than in children with active HIV-1 replication. In children with <50 copies/ml plasma HIV-1, p55-specific responses were detected only in children with evidence of ongoing HIV-1 replication, indicating a direct relationship between HIV-1 replication and HIV-specific CD4(+) T cell frequencies. In contrast, p55-specific proliferative responses were detected more frequently in children with <50 copies/ml plasma HIV-1. CMV-specific CD4(+) responses were more commonly detected and at higher frequencies in CMV-coinfected children with suppressed HIV-1 replication. The lack of HIV-specific CD4(+) proliferative responses, along with the preservation of CMV-specific CD4(+) responses in children with controlled HIV-1 replication, suggests that viral replication may have deleterious effects on HIV-1 and other virus-specific CD4(+) responses. Vaccination to stimulate HIV-specific CD4(+) T cell responses in these children may synergize with antiretroviral therapy to improve the long-term control of viral replication, and may perhaps allow the eventual discontinuation of antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759463     DOI: 10.4049/jimmunol.170.11.5786

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Advances in understanding immunologic control of HIV infection.

Authors:  Stephen A Migueles; John C Tilton; Mark Connors
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

Review 2.  T cell-mediated immune responses in human newborns: ready to learn?

Authors:  A Marchant; M Goldman
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

3.  Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?

Authors:  M Hainaut; V Verscheure; M Ducarme; L Schandené; J Levy; F Mascart
Journal:  Clin Exp Immunol       Date:  2011-04-19       Impact factor: 4.330

4.  Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons.

Authors:  John C Tilton; Alison J Johnson; Marlise R Luskin; Maura M Manion; Jun Yang; Joseph W Adelsberger; Richard A Lempicki; Claire W Hallahan; Mary McLaughlin; Joann M Mican; Julia A Metcalf; Christiana Iyasere; Mark Connors
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

5.  Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.

Authors:  Christiana Iyasere; John C Tilton; Alison J Johnson; Souheil Younes; Bader Yassine-Diab; Rafick-Pierre Sekaly; William W Kwok; Stephen A Migueles; Alisha C Laborico; W Lesley Shupert; Claire W Hallahan; Richard T Davey; Mark Dybul; Susan Vogel; Julia Metcalf; Mark Connors
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.

Authors:  Sihong Huang; Jacqueline Dunkley-Thompson; Yanhua Tang; Eric A Macklin; Julianne Steel-Duncan; Indira Singh-Minott; Elizabeth G Ryland; Monica Smikle; Bruce D Walker; Celia D C Christie; Margaret E Feeney
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

7.  Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.

Authors:  Jennifer A Slyker; Barbara L Lohman; Dorothy A Mbori-Ngacha; Marie Reilly; Edmund G-T Wee; Tao Dong; Andrew J McMichael; Sarah L Rowland-Jones; Tomas Hanke; Grace John-Stewart
Journal:  Vaccine       Date:  2005-02-19       Impact factor: 3.641

8.  Cytomegalovirus and paediatric HIV infection.

Authors:  Jennifer A Slyker
Journal:  J Virus Erad       Date:  2016-10-05

9.  Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.

Authors:  Jérôme Le Chenadec; Daniel Scott-Algara; Stéphane Blanche; Céline Didier; Thomas Montange; Jean-Paul Viard; Catherine Dollfus; Véronique Avettand-Fenoel; Christine Rouzioux; Josiane Warszawski; Florence Buseyne
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

Review 10.  Immunity to HIV in Early Life.

Authors:  Maximilian Muenchhoff; Andrew J Prendergast; Philip Jeremy Renshaw Goulder
Journal:  Front Immunol       Date:  2014-08-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.